Print

Purpose

The primary objective of this study is to show that the Supraglottic Index (SGI) is an easily-collected index that accurately identifies the presence and severity of laryngopharyngeal reflux (LPF) in idiopathic pulmonary fibrosis (IPF).

Conditions

Eligibility

Eligible Ages
Between 40 Years and 95 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Diagnosis of IPF - Age 40-95 - Able to read, speak, and understand English - If subjects are currently taking medication for reflux or GERD, they much be on a stable does for at least 4 weeks prior to consent.

Exclusion Criteria

  • Patients who do not meet all inclusion criteria - Pregnant females

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Recruiting Locations

National Jewish Health
Denver, Colorado 80206
Contact:
Tara Churney, MPH
303-398-1996
ILDresearch@njhealth.org

More Details

Status
Recruiting
Sponsor
National Jewish Health

Study Contact

Matthew Koslow, MPH
303-398-1996
ILDresearch@njhealth.org

Detailed Description

The study team hypothesizes the SGI will correlate more strongly with measures of IPF severity (at baseline and over time) than gastroesophageal reflux (GER) data derived from the esophageal detector channels of a pH/impedance probe.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.